Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Liver Int. 2017 Jan;37(Suppl 1):73–80. doi: 10.1111/liv.13324

Table 1.

DAAs: Inhibitors of nucleocapsid assembly

Drug name Target Compound Stage of Development
GLS4 Interfere with capsid formation/stability Heteroaryldihydropyrimidine (HAPs) Phase II
Bay 41-4109 Viral nucleocapsid inhibitor HAPs Phase I
AT-130 Inhibition of HBV capsid assembly Phenylpropenamide derivatives Preclinical and early clinical phase
NVR-3-778 (NVR1221) Inhibition of HBV capsid assembly Small molecule Phase Ib